| II-09 Claire Ambery Balancing efficacy and risk: A case study of Phase 2 dose selection for an anti-inflammatory drug Wednesday 15:10-16:30 |
| II-09 Claire Ambery Balancing efficacy and risk: A case study of Phase 2 dose selection for an anti-inflammatory drug Wednesday 15:10-16:30 |